[HTML][HTML] Naturally occurring acetylcholinesterase inhibitors and their potential use for Alzheimer's disease therapy

TC Santos, TM Gomes, BAS Pinto… - Frontiers in …, 2018 - frontiersin.org
Alzheimer's disease (AD) is a main cause of dementia, accounting for up to 75% of all
dementia cases. Pathophysiological processes described for AD progression involve …

[HTML][HTML] Natural compounds as medical strategies in the prevention and treatment of psychiatric disorders seen in neurological diseases

E Küpeli Akkol, I Tatlı Çankaya… - Frontiers in …, 2021 - frontiersin.org
Psychiatric disorders are frequently encountered in many neurological disorders, such as
Alzheimer's and Parkinson diseases along with epilepsy, migraine, essential tremors, and …

Acetylcholinesterase inhibitors: pharmacology and toxicology

MB Colovic, DZ Krstic… - Current …, 2013 - ingentaconnect.com
Acetylcholinesterase is involved in the termination of impulse transmission by rapid
hydrolysis of the neurotransmitter acetylcholine in numerous cholinergic pathways in the …

Predicting the current and future distribution of three Coptis herbs in China under climate change conditions, using the MaxEnt model and chemical analysis

J Li, G Fan, Y He - Science of the Total Environment, 2020 - Elsevier
The rhizomes of Coptis chinensis Franch., Coptis deltoidea CY Cheng et Hsiao and Coptis
teeta Wall, are sources of renowned traditional Chinese medicines. Recently, human …

[HTML][HTML] Acetylcholinesterase inhibitors: pharmacology and toxicology

MB Čolović, DZ Krstić, TD Lazarević-Pašti… - Current …, 2013 - ncbi.nlm.nih.gov
Acetylcholinesterase is involved in the termination of impulse transmission by rapid
hydrolysis of the neurotransmitter acetylcholine in numerous cholinergic pathways in the …

Natural AChE inhibitors from plants and their contribution to Alzheimer's disease therapy

AP Murray, MB Faraoni, MJ Castro… - Current …, 2013 - ingentaconnect.com
As acetylcholinesterase (AChE) inhibitors are an important therapeutic strategy in
Alzheimer's disease, efforts are being made in search of new molecules with anti-AChE …

Natural isoquinoline alkaloids: Pharmacological features and multi-target potential for complex diseases

E Plazas, DR Muñoz - Pharmacological Research, 2022 - Elsevier
Complex diseases such as neurodegenerative disorders and cancer constitute a growing
public health problem due to the rising incidence and lack in effective therapies. Since …

[PDF][PDF] Cholinesterases, a target of pharmacology and toxicology.

M Pohanka - Biomedical Papers of the Medical Faculty of …, 2011 - pdfs.semanticscholar.org
Background. Cholinesterases are a group of serine hydrolases that split the neurotransmitter
acetylcholine (ACh) and terminate its action. Of the two types, butyrylcholinesterase and …

Status of acetylcholinesterase and butyrylcholinesterase in Alzheimer's disease and type 2 diabetes mellitus

G Mushtaq, NH Greig, JA Khan… - CNS & Neurological …, 2014 - ingentaconnect.com
Both Alzheimer's disease (AD) and Type 2 diabetes mellitus (T2DM) share the presence of
systemic and neuro-inflammation, enhanced production and accumulation of β-amyloid …

Antioxidant therapies for Alzheimer′ s disease

Y Feng, X Wang - Oxidative medicine and cellular longevity, 2012 - Wiley Online Library
Alzheimer's disease (AD) is the most common neurodegenerative disease featuring
progressive impairments in memory, cognition, and behavior and ultimately leads to death …